Home »
Epilepsy and autism spectrum disorders, or ASD, show a remarkable degree of comorbidity and may share pathological mechanisms. Questions that have bogged down scientists about these disorders include: Does autism lead to an increase in epilepsy? Or does epilepsy alter the brain circuit, which then leads to autism? Viji Santhakumar, an associate professor in the Department of Molecular, Cell and […]
Read more
As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease. But current approaches to designing a fully implantable and biocompatible device able to make such interventions have major limitations: their resolution isn't high enough and most require […]
Read more
A joint task force of the American Epilepsy Society (AES) and International League Against Epilepsy (ILAE) has issued an advisory to address concerns arising from a Food and Drug Administration (FDA) warning of cardiac risk in patients taking the antiseizure drug lamotrigine. The task force is concerned that the FDA warning is based on data not yet widely available, and […]
Read more
In order for a drug to be effective at the right places in the body, it helps if scientists can predict as accurately as possible how the molecules of that drug will interact with human cells. In a joint research project, scientists from Collaborative Research Centre 1423 at Leipzig University and the Chinese Academy of Sciences in Shanghai have succeeded […]
Read more
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS CLOMIPRAMINE Contains the active ingredient, clomipramine (as clomipramine hydrochloride) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine This leaflet answers some common questions about clomipramine. It does not contain all the available information.It does not take […]
Read more
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OXYCODONE MYLAN oxycodone hydrochloride Consumer Medicine Information WARNING Limitations of use OXYCODONE MYLAN should only be used when your doctor decides that other treatment options are not able to effectively manage your pain or you cannot tolerate them. Hazardous and harmful use OXYCODONE MYLAN poses risks of […]
Read more
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-SUMATRIPTAN Sumatriptan succinate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about sumatriptan. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. […]
Read more
Order Medicines & Health Products from Online Pharmacy for Skin, Hair, Heart and all Personal Daily Health. Baby, Men, Women & Elderly care Products Online. Buy prescription medicines, OTC products & household needs.
Read more
Doctors are often failing to inform patients about the risk of birth defects to their unborn babies of a commonly used drug to treat epilepsy, according to a literature review by a University of Manchester researcher. The study by Wejdan Shroukh also reveals that both clinical staff and patients can dangerously misjudge the risk of taking a group of drugs—called […]
Read more
A new study suggests people stop gathering evidence earlier when the data supports their desired conclusion than when it supports the conclusion they wish was false. Filip Gesiarz, Donal Cahill and Tali Sharot of University College London, U.K. report in PLOS Computational Biology. Previous studies had already provided some clues that people gather less information before reaching desirable beliefs. For […]
Read more